Thyrocare Reports Strong Q1FY26 Results with 23% YoY Revenue Growth

New Delhi [India], July 31:  Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has announced its financial results for the first quarter of FY26, ending June 30, 2025. The company reported a consolidated revenue of ₹193.03 crore for Q1FY26, marking a solid 23 percent growth compared to ₹156.91 crore in the same quarter last year.

This growth was largely driven by the company’s core Pathology segment, which posted a 25 percent…